Restart Life Sciences Corp.

Restart Life Sciences Announces Dedicated Purchase Order Financing Through Private Placement Offering

Restart Life Sciences Strengthens Operational Infrastructure to Scale "Better-for-You" Portfolio

Restart Life Sciences Appoints Capital Markets Veteran Lindsay Hamelin to Board of Directors

Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY

Restart Life Advances Holy Crap Growth Strategy with New Protein SKU Nearing Commercialization